News & Hightlights
Learn more about message knowledge from PlexBio
-
September 16, 2024Press & Media
PlexBio Partners with Biomédica Brazil to Pioneer Precision Medicine in Emerging Markets
Learn More -
November 16, 2023Events
PlexBio Showcases Molecular Diagnostics at MEDICA
PlexBio showcased its IntelliPrep™ TRIO 240 Sample Preparation System and IntelliPlex™ Lung Cancer Panel at the MEDICA 2023 held in Düsseldorf, Germany, from November 13th to 16th.
Learn More -
June 09, 2023Events
PlexBio flawlessly demonstrated the Multiplexing Diagnostics platform at Bio Boston 2023
A successful four days at BIO Boston 2023 as we shared our IntelliPlex™ platform.
Learn More
-
Press & Media
PlexBio™100 Fluorescent Analyzer & IntelliPlex™ 1000 πCode Processor obtained the certification of IVDR
May 25, 2023 -
Press & Media
PlexBio and Denka as Strategic Partnerships Announced Successful Achievements of the Deepened Collaborations
February 10, 2023 -
Press & Media
PlexBio won the "2022 Taipei Biotech Awards- Innovation Silver Medal Award
August 12, 2022 -
Press & Media
PlexBio and Denka are launching a one-step SARS-CoV-2 variant detection kit
December 15, 2021 -
-
Press & Media
FDA Grants Emergency Use Authorization for PreciGenome, PlexBio Coronavirus Tests
December 15, 2021 -
-
Press & Media
PlexBio Ranks 51 Among the Top 500 Asia-Pacific High-Growth Companies by Financial Times
December 15, 2021 -
Press & Media
PlexBio Makes the List of 2019 Deloitte Asia Pacific Technology Fast 500
December 15, 2021 -
-
Press & Media
Denka Deepens the Strategic Partnership with PlexBio Through Acquiring Over One-third of Its Stake
December 15, 2021 -
-
-
Press & Media
A. Menarini Diagnostics Signs Exclusive Supply and Distribution Agreement with PlexBio
December 15, 2021